Intellia Therapeutics Inc (NTLA)
Operating Cash Flow Growth
16.57%
Quarterly · Period ending:
NTLA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported16.57%period ending
Latest reported16.57%period ending
NTLA Quarterly Cash from Operations YoY % (54425.00% → 16.57%)
Year-over-year change
High-resolution chart · PNG
NTLA operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 16.5716% | |
| 21.2073% | |
| 18.6748% | |
| 9.3568% | |
| -71.213% | |
| -23.4274% | |
| 8.4456% | |
| 16.3186% | |
| 35.5801% | |
| -10.367% | |
| -3.544% | |
| -29.105% | |
| -6.1487% | |
| -37.0008% | |
| -64.4416% | |
| -20.7684% | |
| -60.6066% | |
| -52.3618% | |
| -35.8599% | |
| -127.684% | |
| -192.2741% | |
| -35.8827% | |
| -40.3461% | |
| -12.221% | |
| 307.4538% | |
| -79.6718% | |
| -235.6992% | |
| -104.336% | |
| -23.0362% | |
| -20.7259% | |
| 59.9268% | |
| 26.2815% | |
| -43.4813% | |
| -55.9045% | |
| -47.8557% | |
| -121.9974% | |
| -123.2095% | |
| -20.985% | |
| -162.4294% | |
| -132.9354% | |
| 3,008.6056% | |
| -295.3754% | |
| -100.8413% | |
| 54,425% |